Therapeutic Monitoring of Psychotropic Drugs
2004; Lippincott Williams & Wilkins; Volume: 26; Issue: 2 Linguagem: Inglês
10.1097/00007691-200404000-00014
ISSN1536-3694
AutoresPierre Baumann, Christoph Hiemke, S. Ulrich, I. Gaertner, M. L. Rao, Gabriel Eckermann, M. Gerlach, Hans‐Joachim Kuss, G. Laux, B. Müller‐Oerlinghausen, Peter Riederer, Gerald Zernig,
Tópico(s)Pharmacological Effects and Toxicity Studies
ResumoTDM of psychotropic drugs is widely used, but there is little consensus regarding its optimal use in the clinical context. This prompted a multidisciplinary group comprised of clinical biochemists, clinical pharmacologists, and psychiatrists of the AGNP (Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie) to provide a consensus guideline. This will allow clinical psychiatrists, practitioners, and laboratory directors involved in psychopharmacotherapy to optimize TDM of antidepressants, antipsychotics, and opioid substituents. Recommendations are also given on the combined use of TDM and pharmacogenetic tests.
Referência(s)